These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12480030)

  • 1. Case of the day.
    Gupta R
    J Emerg Med; 2002 Nov; 23(4):421-2. PubMed ID: 12480030
    [No Abstract]   [Full Text] [Related]  

  • 2. Three hours.
    Smith SD
    Minn Med; 2005 Aug; 88(8):20-3. PubMed ID: 16225330
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 7. Intra-arterial Therapy in the Early Treatment of Acute Ischaemic Stroke.
    Kappelle LJ; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):1-2. PubMed ID: 26363971
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 9. Imaging-guided extension of the time window: ready for application in experienced stroke centers?
    Röther J
    Stroke; 2003 Feb; 34(2):575-83. PubMed ID: 12577994
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of dehydration on the prognosis of acute ischemic stroke for patients treated with tissue plasminogen activator.
    Wu FF; Hung YC; Tsai YH; Yang JT; Lee TH; Liow CW; Lee JD; Lin CJ; Peng TI; Lin LC
    BMC Cardiovasc Disord; 2017 Jun; 17(1):154. PubMed ID: 28610565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis for acute stroke in patients with cancer.
    Casado-Naranjo I; Calle ML; Falcón A; Serrano A; Portilla JC; Ramírez-Moreno JM
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1404-5. PubMed ID: 21084264
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute thrombolytic therapy in stroke: focus on the 3- to 6-hour time window.
    Gorman MJ
    Ethn Dis; 2002; 12(1):S1-54-7. PubMed ID: 11913622
    [No Abstract]   [Full Text] [Related]  

  • 15. Symptomatic intracerebral and systemic hemorrhage after stroke thrombolysis in patients taking ticagrelor.
    Lo KY; Biby S; Sethi P; Campbell BC
    Int J Stroke; 2016 Aug; 11(6):NP71-2. PubMed ID: 27145796
    [No Abstract]   [Full Text] [Related]  

  • 16. Drip-and-ship stroke thrombolysis in the emergency department of a healthcare center - a possibility for those fallen ill in rural settings.
    Kauppila JH; Raatiniemi L; Isokangas JM; Martikainen M; Piironen K
    Duodecim; 2017; 133(2):167-71. PubMed ID: 29205017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IV and IA thrombolytic stroke strategies are complementary.
    Donnan GA; Davis SM
    Stroke; 2009 Jul; 40(7):2615. PubMed ID: 19443794
    [No Abstract]   [Full Text] [Related]  

  • 18. Point-of-care testing for coagulation studies in a stroke protocol: a time-saving innovation.
    Drescher MJ; Spence A; Rockwell D; Staff I; Smally AJ
    Am J Emerg Med; 2011 Jan; 29(1):82-5. PubMed ID: 20825790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should physicians give tPA to patients with acute ischemic stroke? For: thrombolytics in stroke: whose risk is it anyway?
    Robinson DJ
    West J Med; 2000 Sep; 173(3):148-9. PubMed ID: 10986159
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
    Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.